REVIEW
Published on 23 Jan 2023
Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305
doi 10.3389/fphar.2022.979873
- 6,637 views
- 9 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Medicinal chemistry of the PARP-1 inhibitor anti-tumor agents and other natural product derivatives
Medicinal chemistry of the PARP-1 inhibitor anti-tumor agents and other natural product derivatives
3,746
Total downloads
12k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 09 Jan 2023
Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
doi 10.3389/fphar.2022.1054616
- 1,520 views
- 5 citations
ORIGINAL RESEARCH
Published on 13 Jul 2022
A Novel PARP Inhibitor YHP-836 For the Treatment of BRCA-Deficiency Cancers
doi 10.3389/fphar.2022.865085
- 2,263 views
- 2 citations
CASE REPORT
Published on 10 Mar 2022
Case Report: Niraparib-Related Pulmonary Embolism During the Treatment of BRCA Mutant Advanced Ovarian Cancer
doi 10.3389/fonc.2022.853211
- 1,642 views
- 5 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore